Literature DB >> 19124499

Association and interactions between DNA repair gene polymorphisms and adult glioma.

Yanhong Liu1, Michael E Scheurer, Randa El-Zein, Yumei Cao, Kim-Anh Do, Mark Gilbert, Kenneth D Aldape, Qingyi Wei, Carol Etzel, Melissa L Bondy.   

Abstract

It is generally accepted that glioma develops through accumulation of genetic alterations. We hypothesized that polymorphisms of candidate genes involved in the DNA repair pathways may contribute to susceptibility to glioma. To address this possibility, we conducted a study on 373 Caucasian glioma cases and 365 cancer-free Caucasian controls to assess associations between glioma risk and 18 functional single-nucleotide polymorphisms in DNA repair genes. We evaluated potential gene-gene and gene-environment interactions using a multianalytic strategy combining logistic regression, multifactor dimensionality reduction and classification and regression tree approaches. In the single-locus analysis, six single-nucleotide polymorphisms [ERCC1 3' untranslated region (UTR), XRCC1 R399Q, APEX1 E148D, PARP1 A762V, MGMT F84L, and LIG1 5'UTR] showed a significant association with glioma risk. In the analysis of cumulative genetic risk of multiple single-nucleotide polymorphisms, a significant gene-dosage effect was found for increased glioma risk with increasing numbers of adverse genotypes involving the aforementioned six single-nucleotide polymorphisms (P(trend) = 0.0004). Furthermore, the multifactor dimensionality reduction and classification and regression tree analyses identified MGMT F84L as the predominant risk factor for glioma and revealed strong interactions among ionizing radiation exposure, PARP1 A762V, MGMT F84L, and APEX1 E148D. Interestingly, the risk for glioma was dramatically increased in ionizing radiation exposure individuals who had the wild-type genotypes of MGMT F84L and PARP1 A762V (adjusted odds ratios, 5.95; 95% confidence intervals, 2.21-16.65). Taken together, these results suggest that polymorphisms in DNA repair genes may act individually or together to contribute to glioma risk.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124499      PMCID: PMC2917049          DOI: 10.1158/1055-9965.EPI-08-0632

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

1.  O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).

Authors:  Gregory J Tranah; James Bugni; Edward Giovannucci; Jing Ma; Charles Fuchs; Lisa Hines; Leona Samson; David J Hunter
Journal:  Cancer Causes Control       Date:  2006-06       Impact factor: 2.506

2.  Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.

Authors:  Annika Auranen; Honglin Song; Christy Waterfall; Richard A Dicioccio; Bettina Kuschel; Susanne K Kjaer; Estrid Hogdall; Claus Hogdall; John Stratton; Alice S Whittemore; Douglas F Easton; Bruce A J Ponder; Karen L Novik; Alison M Dunning; Simon Gayther; Paul D P Pharoah
Journal:  Int J Cancer       Date:  2005-11-20       Impact factor: 7.396

3.  A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility.

Authors:  Jason H Moore; Joshua C Gilbert; Chia-Ti Tsai; Fu-Tien Chiang; Todd Holden; Nate Barney; Bill C White
Journal:  J Theor Biol       Date:  2006-02-02       Impact factor: 2.691

4.  Polymorphisms in DNA repair genes, medical exposure to ionizing radiation, and breast cancer risk.

Authors:  Robert C Millikan; Jon S Player; Allan Rene Decotret; Chiu-Kit Tse; Temitope Keku
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

5.  Genotyping of patients with sporadic and radiation-associated meningiomas.

Authors:  Siegal Sadetzki; Pazit Flint-Richter; Sigal Starinsky; Ilya Novikov; Yehuda Lerman; Boleslaw Goldman; Eitan Friedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

Review 6.  Molecular pathogenesis of malignant gliomas.

Authors:  B K Rasheed; R N Wiltshire; S H Bigner; D D Bigner
Journal:  Curr Opin Oncol       Date:  1999-05       Impact factor: 3.645

Review 7.  XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.

Authors:  Maurizio Manuguerra; Federica Saletta; Margaret R Karagas; Marianne Berwick; Fabrizio Veglia; Paolo Vineis; Giuseppe Matullo
Journal:  Am J Epidemiol       Date:  2006-05-17       Impact factor: 4.897

8.  DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents.

Authors:  B J Glassner; G Weeda; J M Allan; J L Broekhof; N H Carls; I Donker; B P Engelward; R J Hampson; R Hersmus; M J Hickman; R B Roth; H B Warren; M M Wu; J H Hoeijmakers; L D Samson
Journal:  Mutagenesis       Date:  1999-05       Impact factor: 3.000

Review 9.  Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review.

Authors:  Rayjean J Hung; Janet Hall; Paul Brennan; Paolo Boffetta
Journal:  Am J Epidemiol       Date:  2005-10-12       Impact factor: 4.897

Review 10.  Mechanisms of disease: DNA repair defects and neurological disease.

Authors:  Kalluri Subba Rao
Journal:  Nat Clin Pract Neurol       Date:  2007-03
View more
  72 in total

1.  Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis.

Authors:  Hongping Yu; Hongxia Ma; Ming Yin; Qingyi Wei
Journal:  Genet Epidemiol       Date:  2011-11-29       Impact factor: 2.135

Review 2.  Cancer risks associated with external radiation from diagnostic imaging procedures.

Authors:  Martha S Linet; Thomas L Slovis; Donald L Miller; Ruth Kleinerman; Choonsik Lee; Preetha Rajaraman; Amy Berrington de Gonzalez
Journal:  CA Cancer J Clin       Date:  2012-02-03       Impact factor: 508.702

3.  Correlations of MGMT genetic polymorphisms with temozolomide resistance and prognosis of patients with malignant gliomas: a population-based study in China.

Authors:  H-W Wang; Z-K Xu; Y Song; Y-G Liu
Journal:  Cancer Gene Ther       Date:  2017-04-14       Impact factor: 5.987

4.  DNA repair gene XRCC3 Thr241Met polymorphism and glioma risk: a meta-analysis.

Authors:  Bao Zhao; Jingliang Ye; Bin Li; Qiang Ma; Guojun Su; Ruizhang Han
Journal:  Int J Clin Exp Med       Date:  2013-06-26

5.  Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.

Authors:  Weijie Zhu; Jie Yao; Yi Li; Bainan Xu
Journal:  Tumour Biol       Date:  2013-11-21

6.  Genetic Modulation of Neurocognitive Function in Glioma Patients.

Authors:  Yanhong Liu; Renke Zhou; Erik P Sulman; Michael E Scheurer; Nicholas Boehling; Georgina N Armstrong; Spiridon Tsavachidis; Fu-Wen Liang; Carol J Etzel; Charles A Conrad; Mark R Gilbert; Terri S Armstrong; Melissa L Bondy; Jeffrey S Wefel
Journal:  Clin Cancer Res       Date:  2015-04-22       Impact factor: 12.531

7.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

8.  A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.

Authors:  Xiangtai Wei; Duo Chen; Tao Lv
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

9.  Three polymorphisms of DNA repair gene XRCC1 and the risk of glioma: a case-control study in northwest China.

Authors:  Gaofeng Xu; Maode Wang; Wanfu Xie; Xiaobin Bai
Journal:  Tumour Biol       Date:  2013-09-19

10.  Association Between PARP1 Single Nucleotide Polymorphism and Brain Tumors.

Authors:  Hong Wang; Kun Zhang; Haifeng Qin; Lin Yang; Liyu Zhang; Yanyan Cao
Journal:  Mol Neurobiol       Date:  2015-04-25       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.